W ith the clinical knowledge available to them, clinicians can have a significant impact on the resources used to fund NSAID treatment and on the incidence of adverse reactions. Regrettably, clinical behaviour in the field of NSAID use continues, in many instances, to be inappropriate, damaging to patients and very expensive, according to Professor Alan Maynard, Director of the Centre of Health Economics at York University, UK. He tackled these issues, highlighting the various options available for improving the cost effectiveness of NSAID therapy, at the 10th World Congress of Gastroenterology [Los Angeles, USA; October 1994].
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
About this article
Cite this article
Langsdale, T., Stather, R. NSAID prescribing - in need of treatment?. Pharmacoecon. Outcomes News 18, 8–9 (1994). https://doi.org/10.1007/BF03289961
- 10th World
- Clinical Knowledge
- Nsaid Therapy
- Gastric Damage